Pharmacokinetics of concentrated naloxone nasal spray for opioid overdose reversal: Phase I healthy volunteer study

Publisher： John Wiley & Sons Inc

E-ISSN： 1360-0443|113|3|484-493

ISSN： 0965-2140

Source： ADDICTION, Vol.113, Iss.3, 2018-03, pp. : 484-493

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Naloxone—does over‐antagonism matter? Evidence of iatrogenic harm after emergency treatment of heroin/opioid overdose

By  

ADDICTION, Vol. 110, Iss. 10, 2015-10 ,pp. : 1644-1652

John Wiley & Sons Inc

Access to resources Recommend Favorite

Stopped hearts, amputated toes and NASA: contemporary legends among healthy volunteers in US phase I clinical trials

By  

SOCIOLOGY OF HEALTH & ILLNESS, Vol. 37, Iss. 1, 2015-01 ,pp. : 127-142

John Wiley & Sons Inc

Access to resources Recommend Favorite

Commentary on Gjersing

By  

ADDICTION, Vol. 110, Iss. 11, 2015-11 ,pp. : 1775-1776

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predictors of participant engagement and naloxone utilization in a community‐based naloxone distribution program

By  

ADDICTION, Vol. 110, Iss. 8, 2015-08 ,pp. : 1301-1310

John Wiley & Sons Inc

Access to resources Recommend Favorite

Parliamentary Reversal of the Osborne Judgement

By  

The Historical Journal, Vol. 32, Iss. 4, 1989-12 ,pp. : 893-924

Cambridge University Press

Access to resources Recommend Favorite